Gene transfer with a vector expressing Maxi-K from a smooth muscle-specific promoter restores erectile function in the aging rat

Gene Therapy

Volumn 15, Issue 5, 2008, Pages 364-370

  Melman, A ^a   Biggs, G ^a   Davies, K ^a   Zhao, W ^b   Tar, M T ^a   Christ, G J ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CORPUS CAVERNOSUM; ERECTILE DYSFUNCTION; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; MALE; NERVE STIMULATION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PENIS ERECTION; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE;

ACTINS; AGING; ANIMALS; ELECTRIC STIMULATION; ERECTILE DYSFUNCTION; GENE THERAPY; GENETIC ENGINEERING; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNITS; MALE; MODELS, ANIMAL; MUSCLE, SMOOTH; PENIS; PROMOTER REGIONS (GENETICS); RATS; RATS, SPRAGUE-DAWLEY; TRANSFECTION;

CYTOMEGALOVIRUS; RATTUS;

EID: 39449121888     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3303093     Document Type: Article

References (31)

1. Araujo A, Mohr B, McKinlay J. Changes in sexual function in middle-aged and older men: Longitudinal data from the Massachusetts Male Aging Study. J Am Geriatr Soc 2004; 52: 1502-1509.
2. Marumo K, Nakashima J, Muria M. Age-related prevalence of erectile dysfunction in Japan: Assessment by the international index of erectile function. Int J Urol 2001; 8: 53-59.
3. Melman A, Gingell JC. The epidemiology and pathophysiology of erectile dysfunction. J Urol 1999; 161: 5-11.
4. Benet AE, Melman A. The epidemiology of erectile dysfunction. Urol Clin North Am 1995; 22: 699-709.
5. Garban H, Marquez D, Liping C, Rajfer J, Gonzalez-Cadavid N. Restoration of normal adult penile erectile response in aged rats by long term treatment with androgens. Bio Reprod 1995; 53: 1365-1372.
6. Lerner SE, Melman A, Christ GJ. A review of erectile dysfunction: New insights and more questions. J Urol 1993; 149: 1246-1255.
7. Melman A, Christ GJ. The hemodynamics of erection and the pharmacotherapies of erectile dysfunction. Heart Dis 2002; 4 252-264.
8. Melman A, Christ GJ. Integrative erectile biology. The effects of age and disease on gap junctions and ion channels and their potential value to the treatment of erectile dysfunction. Urol Clin North Am 2001; 28: 217-231, vii.
9. Wespes E. Smooth muscle pathology and erectile dysfunction. Int J Impot Res 2002; 14: S17-S21.
10. Ferrini M, Magee T, Vernet D, Rajfer J, Gonzalez-Cadavid N. Aging-related expression of inducible nitric oxide synthase and marker of tissue damage in the rat penis. Bio Reprod 2001; 64: 974-982.
11. Chang S, Hypolite JA, Changolkar A, Wein AJ, Chacko S, DiSanto ME. Increased contractility of diabetic rabbit corpora smooth muscle in response to endothelin is mediated via Rho-kinase-beta. Int J Impot Res 2003; 15: 53-62.
12. Li J, Wang G, Qin W, Yang Y. Effect of aging on the endothelial function of the penile corpus cavernosum in rats. Zonghua Nan Ke Xue 2004; 10: 824-826.
13. Korovkina VP, England SK. Detection and implications of potassium channel alterations. Vascul Pharmacol 2002; 38: 3-12.
14. Christ GJ, Rehman J, Day N, Salkoff L, Valcic M, Melman A et al. Intracorporal injection of hSlo cDNA in rats produces physiologically relevant alterations in penile function. Am J Physiol 1998; 275 H600-H608.
15. Melman A, Zhao W, Davies KP, Bakal R, Christ GJ. The successful long-term treatment of age related erectile dysfunction with hSlo cDNA in rats in vivo. J Urol 2003; 170: 285-290.
16. Christ GJ, Day N, Sato Y, Zhao W, Sclanfani T, Bakal R et al. Intracorporal injection of hSlo cDNA restores erectile capacity in STZ-diabetic F-344 rats in vivo. Am J Physiol Heart Circ Physiol 2004; 287: H1544-H1553.
17. Melman A, Bar-Chama N, McCullough A, Davies K, Christ G. The first human trial for gene transfer therapy for the treatment of enrectile dysfunction preliminary results. Eur Urol 2005; 48: 314-318.
18. Melman A, Bar-Chama N, McCullough A, Davies K, Christ G. hMaxi-K gene transfer in males with erectile dysfunction: Results of the first hupian trial. Hum Gene Ther 2006; 18: 1165-1176.
19. Pritchard TJ, Parvatiyar M, Bullard DP, Lynch RM, Lorenz JN, Paul RJ. Transgenic mice expressing Na+-K+-ATPase in smooth muscle decreases blood pressure. Am J Physiol Heart Circ Physiol 2007; 293: H1172-H1182.
20. Knott AW, Juno RJ, Jarboe MD, Profitt SA, Erwin CR, Smith EP et al Smooth muscle overexpression of IGF-I induces a novel adaptive response to small bowel resection. Am J Physiol Gastrointest Liver Physiol 2004; 287: G562-G570.
21. Gokturk C, Nilsson J, Nordquist J, Kristensson M, Svensson K, Soderberg C et al. Overexpression of semicarbazide-sensitive amine oxidase in smooth muscle cells leads to an abnormal structure of the aortic elastic laminas. Am J Pathol 2003; 163: 1921-1928.
22. Noonan WT, Qian J, Stuart WD, Clemens TL, Lorenz JN. Altered renal hemodynamics in mice overexpressing the parathyroid hormone (PTH)/ PTH-related peptide type 1 receptor in smooth muscle. Endocrinology 2003; 144: 4931-4938.
23. Zhang M, Smith EP, Kuroda H, Banach W, Chernausek SD, Fagin JA. Targeted expression of a protease-resistant IGFBP-4 mutant in smooth muscle of transgenic mice results in IGFBP-4 stabilization and smooth muscle hypotrophy. J Biol Chem 2002; 277: 21285-21290.
24. Zhao G, Sutliff RL, Weber CS, Wang J, Lorenz J, Paul RJ et al. Smooth muscle-targeted overexpression of insulin-like growth factor I results in enhanced vascular contractility. Endocrinology 2001; 142: 623-632.
25. Qian J, Lorenz JN, Maeda S, Sutliff RL, Weber C, Nakayama T et al. Reduced blood pressure and increased sensitivity of the vasculature to parathyroid hormone-related protein (PTHrP) in transgenic mice overexpressing the PTH/PTHrP receptor in vascular smooth muscle. Endocrinology 1999; 140: 1826-1833.
26. Wang J, Niu W, Witte DP, Chernausek SD, Nikiforov YE, Clemens TL et al. Overexpression of insulin-like growth factor-binding protein-4 (IGFBP-4) in smooth muscle cells of transgenic mice through a smooth muscle alpha-actin-IGFBP-4 fusion gene induces smooth muscle hypoplasia. Endocrinology 1998; 139: 2605-2614.
27. Nakano Y, Nishihara T, Sasayama S, Miwa T, Kamada S, Kakunaga T. Transcriptional regulatory elements in the 5′ upstream and first regions of the humans smooth muscle (aortic type) alpha-actin-encoding gene. Gene 1991; 99: 285-289.
28. Yang Z-H, Kitami Y, Takata Y, Okura T, Hiwada K. Targeted overexpression CCAAT/enhanced-binding protein-d evokes enhanced gene transcription of platelet-derived growth factor alpha-receptor in vascular smooth muscle cells. Circ Res 2001; 89: 503-508.
29. Rolland A. Gene medicines: The end of the beginning? Adv Drug Deliv Rev 2005; 57: 669-673.
30. Szucik JC, Lewis AG, Marmer DJ, Lessard JL. Urogenital tract expression of enhanced green fluorescent in transgenic mice driven by a smooth muscle [gamma]-actin promoter. J Urol 2004; 171: 944-949.
31. Christ GJ, Liebert M. Proceedings of the Baltimore smooth muscle meeting: Identifying research frontiers and priorities for the lower urinary tract. J Urol 2005; 173: 1406-1409.